Inhibition of Chk1 abrogates differential cell cycle responses to cisplatin whilst enhancing cytotoxicity
Main Author: | Thompson, Ruth Helen |
---|---|
Published: |
University of Sheffield
2010
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.527234 |
Similar Items
-
SiRNA inhibition of PRKC-σ-vb expression abrogates the aggressive phenotype of human prostate cancer cells
by: Yao, Sheng
Published: (2009) -
The response of human tumour cells to radiation and cytotoxic drugs
by: Smith, Ian Edward
Published: (1978) -
The characterization of non-cycling cells in acute myeloid leukaemia and sensitivity to FLT3 inhibition in vitro
by: Alvares, Caroline Lilian
Published: (2011) -
The role of histone deacetylase 4 (HDAC4) in acquired cisplatin-resistant ovarian cancer
by: Alfraidi, Albanderi Mohammed
Published: (2011) -
Investigating the role of Chk1 in mouse skin homeostasis and tumourigenesis
by: Tho, Lye Mun
Published: (2011)